Actelis Files S-1 for White Lion Resale, Eyes $30M ELOC Amid Reverse Split Vote

Ticker: ASNS · Form: S-1 · Filed: Oct 7, 2025 · CIK: 1141284

Sentiment: bearish

Topics: S-1 Filing, Equity Line of Credit, Dilution Risk, Reverse Stock Split, Nasdaq Compliance, White Lion Capital, Cyber-Hardened Networking

Related Tickers: ASNS

TL;DR

**ASNS is setting up for massive dilution with White Lion's share resale, and the looming reverse split vote screams desperation; steer clear.**

AI Summary

Actelis Networks, Inc. (ASNS) filed an S-1 on October 7, 2025, for the resale of up to 15,200,000 shares of common stock by White Lion Capital, LLC. This offering includes 10,000,000 shares from an equity line of credit (ELOC Purchase Agreement), 1,200,000 commitment shares (valued at $0.625 per share), 871,766 shares from a private placement (PIPE Purchase Agreement), and 3,128,234 shares issuable upon exercise of Pre-Funded Warrants. Actelis will not receive any proceeds from White Lion's sale of these shares, but may receive up to $30.0 million in aggregate gross proceeds from White Lion under the ELOC Purchase Agreement for shares sold to them. The company's common stock closed at $0.65 per share on October 6, 2025, on the Nasdaq Capital Market. A proposed reverse stock split of 1-for-7 to 1-for-12 is scheduled for a shareholder vote on November 7, 2025, indicating potential concerns about Nasdaq listing compliance.

Why It Matters

This S-1 filing signals a significant potential for dilution for existing ASNS investors, as White Lion Capital plans to resell up to 15.2 million shares, which could depress the stock price from its current $0.65. While Actelis could receive up to $30.0 million from White Lion via the equity line, the timing and pricing of these sales are uncertain, impacting the company's ability to fund its cyber-hardened networking solutions. The proposed reverse stock split, to be voted on November 7, 2025, further highlights the company's struggle to maintain Nasdaq listing requirements, putting it at a competitive disadvantage against larger, more stable networking solution providers.

Risk Assessment

Risk Level: high — The filing explicitly states, "Sales of a substantial number of our shares of Common Stock in the public market by the selling stockholder... could increase the volatility of and cause a significant decline in the market price of our securities." Furthermore, the company's stock price was $0.65 on October 6, 2025, and a proposed reverse stock split of 1-for-7 to 1-for-12 is scheduled for a shareholder vote on November 7, 2025, indicating a high risk of delisting or significant price erosion.

Analyst Insight

Investors should exercise extreme caution and consider divesting ASNS shares due to the high risk of dilution from White Lion's resale of up to 15.2 million shares and the potential negative impact of the proposed reverse stock split. The uncertainty surrounding the $30.0 million ELOC proceeds and the company's ability to maintain Nasdaq compliance further compounds the risk.

Financial Highlights

debt To Equity
N/A
revenue
$11.2 million
operating Margin
-129.5%
total Assets
$10.5 million
total Debt
$0.0 million
net Income
-$14.5 million
eps
-$1.75
gross Margin
25.0%
cash Position
$1.1 million
revenue Growth
-14.0%

Key Numbers

Key Players & Entities

FAQ

What is the purpose of Actelis Networks' S-1 filing on October 7, 2025?

The S-1 filing by Actelis Networks, Inc. on October 7, 2025, is for the registration of up to 15,200,000 shares of common stock for resale by White Lion Capital, LLC. This includes shares from an equity line of credit, commitment shares, and shares from a private placement.

How much money will Actelis Networks receive from the sale of shares by White Lion Capital?

Actelis Networks will not receive any proceeds from White Lion Capital's sale of the 15,200,000 shares registered in this S-1. However, Actelis may receive up to $30.0 million in aggregate gross proceeds from White Lion under the ELOC Purchase Agreement in connection with future sales of shares to White Lion.

What is the potential impact of this S-1 filing on Actelis Networks' stock price?

The S-1 filing indicates a high potential for dilution, as the resale of up to 15,200,000 shares by White Lion Capital could increase volatility and cause a significant decline in Actelis Networks' stock price, which was $0.65 per share on October 6, 2025.

What is the 'ELOC Purchase Agreement' mentioned in the Actelis Networks S-1?

The ELOC Purchase Agreement, dated September 27, 2025, establishes an equity line of credit between Actelis Networks and White Lion Capital, LLC. Under this agreement, Actelis may elect to issue and sell up to 10,000,000 shares of common stock to White Lion over time.

What is the 'PIPE Purchase Agreement' in the context of Actelis Networks' filing?

The PIPE Purchase Agreement, also dated September 27, 2025, is a Stock Purchase Agreement between Actelis Networks and White Lion Capital, LLC, entered into for a private placement of the company's securities. This agreement resulted in 871,766 shares being issued and 3,128,234 shares issuable upon exercise of Pre-Funded Warrants.

Is Actelis Networks planning a reverse stock split?

Yes, Actelis Networks called for an extraordinary general meeting of shareholders on September 29, 2025, to approve a reverse share split of its authorized common stock at a ratio of 1-for-7 to 1-for-12. The meeting is scheduled for November 7, 2025.

Why would Actelis Networks consider a reverse stock split?

Companies often consider a reverse stock split to increase their per-share price, primarily to regain or maintain compliance with stock exchange listing requirements, such as those of the Nasdaq Capital Market, which typically require a minimum bid price.

Who is Tuvia Barlev at Actelis Networks?

Tuvia Barlev is the Chief Executive Officer and Chairman of the Board of Directors for Actelis Networks, Inc. He is listed as the agent for service in the S-1 filing.

What are the primary risks highlighted in the Actelis Networks S-1 filing?

Key risks include the potential for significant dilution and stock price decline due to the resale of 15,200,000 shares by White Lion Capital, the company's history of losses, the need for additional capital, and the ability to maintain Nasdaq listing requirements, as evidenced by the proposed reverse stock split.

What kind of solutions does Actelis Networks provide?

Actelis Networks provides cyber-hardened, rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local government, intelligent traffic systems, military, utility, rail, telecom, and campus applications. Their solutions utilize hybrid fiber and existing copper/coaxial lines.

Risk Factors

Industry Context

Actelis Networks operates in the highly competitive telecommunications equipment sector, which is characterized by rapid technological advancements and consolidation. Key trends include the ongoing deployment of 5G networks, the increasing demand for high-speed data transmission, and the shift towards software-defined networking solutions. Companies in this space must continuously innovate to maintain market relevance and secure contracts with service providers and enterprises.

Regulatory Implications

The proposed reverse stock split is a direct response to potential non-compliance with Nasdaq's minimum bid price rule. Failure to maintain compliance could result in delisting, severely impacting liquidity and investor confidence. The company's reliance on equity financing also subjects it to SEC regulations regarding public offerings and disclosures.

What Investors Should Do

  1. Monitor the outcome of the November 7th shareholder vote on the reverse stock split.
  2. Analyze the terms and execution of the ELOC with White Lion Capital.
  3. Evaluate the company's cash burn rate and runway.
  4. Assess the competitive positioning and product differentiation.

Key Dates

Glossary

S-1 Filing
A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. (This is the primary document detailing the company's financial status, business operations, and risks associated with the securities being offered.)
Equity Line of Credit (ELOC)
An agreement where a company can sell shares to an investor (like White Lion Capital) at its discretion over a period, up to a certain amount. (Actelis may receive up to $30.0 million in proceeds from White Lion under this agreement, crucial for its ongoing operations and financing needs.)
Commitment Shares
Shares issued to an investor as part of an agreement, often to compensate them for entering into a financing arrangement. (White Lion Capital receives 1,200,000 commitment shares, indicating a cost associated with securing the ELOC financing.)
PIPE Purchase Agreement
Private Investment in Public Equity. An agreement for private investors to purchase securities from a public company. (Actelis issued 871,766 shares and Pre-Funded Warrants to White Lion Capital under this agreement, part of the overall financing structure.)
Pre-Funded Warrants
Warrants that allow the holder to purchase shares at a nominal exercise price, effectively representing immediate ownership of the underlying shares. (3,128,234 shares are issuable upon exercise of these warrants, part of the PIPE transaction, and represent a significant portion of the shares being registered.)
Reverse Stock Split
A corporate action where a company reduces the number of outstanding shares by consolidating them, typically to increase the per-share price. (Actelis is considering a 1-for-7 to 1-for-12 reverse split, likely to meet Nasdaq's minimum bid price requirement and avoid delisting.)
Going Concern
A business assumption that the entity will continue to operate for the foreseeable future, typically at least 12 months. (The S-1 filing often includes disclosures about whether management has substantial doubt about the company's ability to continue as a going concern, which is a significant risk indicator.)

Year-Over-Year Comparison

This S-1 filing represents a significant financing event for Actelis Networks, Inc. While specific comparative financial data from a prior S-1 filing is not detailed here, the current filing highlights a substantial number of shares being registered for resale by White Lion Capital, including those from an ELOC and PIPE transaction. This suggests a continued reliance on external capital to fund operations, a common theme for companies in this stage. The proposed reverse stock split also points to ongoing challenges in meeting stock exchange listing requirements, a critical factor for investor confidence and liquidity.

Filing Stats: 4,405 words · 18 min read · ~15 pages · Grade level 17.5 · Accepted 2025-10-07 17:25:12

Key Financial Figures

Filing Documents

Use of Proceeds

Use of Proceeds 9 White Lion Transaction 10 Selling Stockholder 12 Description of Offered Securities 13 Plan of Distribution 18 Legal Matters 19 Experts 19 Where You Can Find More Information 19 Incorporation of Certain Information by Reference 20 i ABOUT THIS PROSPECTUS Unless the context indicates otherwise, references in this prospectus to “Actelis,” “we,” “us,” “our,” “the Company,” “our company” and similar terms refer to Actelis Networks, Inc., a Delaware corporation. Actelis has a wholly-owned subsidiary, Actelis Networks Israel, Ltd, an Israeli company. This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”). The selling stockholder named in this prospectus may from time to time sell the securities described in the prospectus. You should read this prospectus together with the more detailed information regarding our company, our Common stock, and our financial statements and notes to those statements that appear elsewhere in this prospectus and any applicable prospectus supplement together with the additional information that we incorporate in this prospectus by reference, which we describe under the heading “Where You Can Find More Information.” You should rely only on the information contained in, or incorporated by reference in, this prospectus and in any accompanying prospectus supplement. We have not authorized anyone to provide you with different information from that contained in, or incorporated by reference in, this prospectus. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date on the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date. You should not consider this prospectus to be an offer or

Forward-looking statements

Forward-looking statements are based on our management’s current expectations, estimates, forecasts and projections about our business and the industry in which we operate and our management’s beliefs and assumptions, and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking include, among other things, those listed under “Risk Factors,” “Use of Discussion and Analysis of Financial Condition and Results of Operations,” “Business” and elsewhere herein or by incorporation by reference. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. You should read thoroughly this prospectus and the documents that we refer to with the understanding that our actual future results may be materially different from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements. The forward-looking statements included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations reflected in the forward-looking in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this prospectus. See “Where You Can Find More Information.&rd

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing